Katie Stamp

613 total citations
9 papers, 111 citations indexed

About

Katie Stamp is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Katie Stamp has authored 9 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Katie Stamp's work include Protein Degradation and Inhibitors (3 papers), CAR-T cell therapy research (2 papers) and Ubiquitin and proteasome pathways (2 papers). Katie Stamp is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), CAR-T cell therapy research (2 papers) and Ubiquitin and proteasome pathways (2 papers). Katie Stamp collaborates with scholars based in United Kingdom, United States and Germany. Katie Stamp's co-authors include Dale Fisher, Stephen Duckett, Ruth Roberts, Sally Robinson, R.D. Callander, Alison Bigley, David P. Ryan, Lyn H. Jones, Mohan Rao and Constance A. Mitchell and has published in prestigious journals such as Nature Reviews Drug Discovery, Drug Discovery Today and Regulatory Toxicology and Pharmacology.

In The Last Decade

Katie Stamp

8 papers receiving 98 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katie Stamp United Kingdom	5	32	31	21	13	12	9	111
Joanne Nguyen United States	8	62 1.9×	7 0.2×	11 0.5×	26 2.0×	3 0.3×	19	245
Mohammad M. AlAhmad United Arab Emirates	7	28 0.9×	13 0.4×	5 0.2×	5 0.4×		25	166
Sebastian Albers Germany	7	26 0.8×	15 0.5×	52 2.5×	21 1.6×	1 0.1×	18	204
Larry D. Sasich Saudi Arabia	6	32 1.0×	16 0.5×	23 1.1×	3 0.2×	2 0.2×	13	141
Robyn Lim Canada	6	19 0.6×	20 0.6×	123 5.9×	8 0.6×	2 0.2×	12	206
Lucy Shneyer United States	7	18 0.6×	7 0.2×	27 1.3×	8 0.6×		12	230
Rameswari Chilamakuri United States	5	57 1.8×	6 0.2×	12 0.6×	20 1.5×		12	248
Josep Torrent-Farnell Spain	6	28 0.9×	15 0.5×	164 7.8×	7 0.5×		10	256
Emanuela Taioli United States	6	70 2.2×	19 0.6×	8 0.4×	21 1.6×	1 0.1×	7	214
Randall A. Oyer United States	8	19 0.6×	39 1.3×	39 1.9×	6 0.5×		25	170

Countries citing papers authored by Katie Stamp

Since Specialization

Citations

This map shows the geographic impact of Katie Stamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Stamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Stamp more than expected).

Fields of papers citing papers by Katie Stamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Stamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Stamp. The network helps show where Katie Stamp may publish in the future.

Co-authorship network of co-authors of Katie Stamp

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Stamp. A scholar is included among the top collaborators of Katie Stamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Stamp. Katie Stamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Burdick, Andrew D., Annick Cauvin, Anthony M. DeLise, et al.. (2025). Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider. Regulatory Toxicology and Pharmacology. 158. 105793–105793. 1 indexed citations

Zhu, Dan, Haralambos Hadjivassiliou, David Mikolon, et al.. (2024). CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma. mAbs. 16(1). 2310248–2310248. 3 indexed citations

Whitehead, Emma, et al.. (2023). P90 Tailoring the need for combination immunosuppressive therapy in IBD patients initiating anti-TNF agents using pre-biologic HLA-DQA1*05 screening: a prospective study. Poster presentations. A100.2–A101.

Stamp, Katie, et al.. (2023). Industry perspective on the nonclinical safety assessment of heterobifunctional degraders. Drug Discovery Today. 28(8). 103643–103643. 9 indexed citations

Jones, Lyn H., Constance A. Mitchell, Mira Pavkovic, et al.. (2022). Targeted protein degraders: a call for collective action to advance safety assessment. Nature Reviews Drug Discovery. 21(6). 401–402. 16 indexed citations

Myers, Sally, et al.. (2020). React, reset and restore: Adaptation of a large inflammatory bowel disease service during COVID-19 pandemic. Clinical Medicine. 20(5). e183–e188. 3 indexed citations

Ryan, David P., et al.. (2013). Target organ toxicities in studies conducted to support first time in man dosing: An analysis across species and therapy areas. Regulatory Toxicology and Pharmacology. 65(3). 334–343. 26 indexed citations

Stamp, Katie, et al.. (2013). Comparison of Computerized Image Analysis with Traditional Semiquantitative Scoring of Perls’ Prussian Blue Stained Hepatic Iron Deposition. Toxicologic Pathology. 41(7). 992–1000. 18 indexed citations

Stamp, Katie, Stephen Duckett, & Dale Fisher. (1998). Hospital use for potentially preventable conditions in Aboriginal and Torres Strait Islander and other Australian populations. Australian and New Zealand Journal of Public Health. 22(6). 673–678. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact